Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.66 |
| ▸ | CA2 | P00918 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31148962 | 0.96 | CA1 (0.66) | CA1CA2KDM4EGAAALDH1A1 | |
| SCHEMBL13527526 | 0.83 | GAA (0.58) | KDM4EGAAALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL9637773 | 0.83 | KDM4E (0.63) | KDM4EGAAALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL26497795 | 0.82 | CA1 (0.50) | CA1CA2KDM4EGAAALDH1A1 | |
| SCHEMBL8437113 | 0.82 | KDM4E (0.71) | KDM4EGAAALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL29598340 | 0.81 | NPC1 (0.68) | CA1CA2KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL667723 | 0.81 | NPC1 (0.68) | CA1CA2KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL7959771 | 0.81 | PLK1 (0.64) | KDM4EGAAALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL6465455 | 0.81 | CA1 (0.64) | CA1CA2KDM4EGAAALDH1A1 | |
| SCHEMBL15328092 | 0.80 | GAA (0.54) | KDM4EGAAALDH1A1SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4536385-B1 | FILTRATION MEMBRANE WITH IMPROVED HYDROPHILICITY | BASF SE (DE) | 2026-03-04 | — | — | EP | claimed |
| EP-4486822-B1 | PROCESS FOR THE PREPARATION OF A MEMBRANE (M) CONTAINING A SULFONATED POLYARYLENESULFONE POLYMER (SP) | BASF SE (DE) | 2025-11-26 | — | — | EP | claimed |
| US-20250158098-A1 | PROCESS FOR THE PREPARATION OF A MEMBRANE (M) CONTAINING A SULFONATED POLYARYLENESULFONE POLYMER (SP) | BASF SE (DE) | 2025-05-15 | — | — | US | claimed |
| EP-4536385-A1 | FILTRATION MEMBRANE WITH IMPROVED HYDROPHILICITY | BASF SE (DE) | 2025-04-16 | — | — | EP | claimed |
| EP-4486822-A1 | PROCESS FOR THE PREPARATION OF A MEMBRANE (M) CONTAINING A SULFONATED POLYARYLENESULFONE POLYMER (SP) | BASF SE (DE) | 2025-01-08 | — | — | EP | claimed |
| US-12110368-B2 | Polyarylene ether sulfone | BASF SE (DE) | 2024-10-08 | — | — | US | claimed |
| WO-2023237365-A1 | FILTRATION MEMBRANE WITH IMPROVED HYDROPHILICITY | BASF SE (DE) | 2023-12-14 | — | — | WO | claimed |
| WO-2023161356-A1 | PROCESS FOR THE PREPARATION OF A MEMBRANE (M) CONTAINING A SULFONATED POLYARYLENESULFONE POLYMER (SP) | BASF SE (DE) | 2023-08-31 | — | — | WO | claimed |
| EP-3850033-B1 | POLYARYLENE ETHER SULFONE | BASF SE (DE) | 2023-05-17 | — | — | EP | claimed |
| US-20220056216-A1 | POLYARYLENE ETHER SULFONE | BASF SE (DE) | 2022-02-24 | — | — | US | claimed |
| EP-4536385-B1 | FILTRATION MEMBRANE WITH IMPROVED HYDROPHILICITY | BASF SE (DE) | 2026-03-04 | — | — | EP | disclosed |
| EP-4486822-B1 | PROCESS FOR THE PREPARATION OF A MEMBRANE (M) CONTAINING A SULFONATED POLYARYLENESULFONE POLYMER (SP) | BASF SE (DE) | 2025-11-26 | — | — | EP | disclosed |
| US-20250346588-A1 | IMIDAZOPYRIDINE AND OXAZOLOPYRIDINE DERIVATIVES AND ANALOGS THEREOF, METHODS OF PREPARATION THEREOF, METHODS OF HIF-1/2A PATHWAY INHIBITION, AND INDUCTION OF FERROPTOSIS | KUDA THERAPEUTICS INC (US) | 2025-11-13 | — | — | US | disclosed |
| EP-4370604-B1 | THERMOPLASTIC MOLDING COMPOSITION WITH HIGH TEMPERATURE RESISTANCE COMPRISING A POLYPHENYLENE SULFIDE | BASF SE (DE) | 2025-08-06 | — | — | EP | disclosed |
| EP-4370605-B1 | THERMOPLASTIC MOLDING COMPOSITION WITH HIGH TEMPERATURE RESISTANCE COMPRISING A THERMOTROPIC POLYMER | BASF SE (DE) | 2025-08-06 | — | — | EP | disclosed |
| US-20020002152-A1 | Hydrazide and alkoxyamide angiogenesis inhibitors | ABBOTT LABORATORIES | 2002-01-03 | — | — | US | disclosed |
| WO-2001079157-A1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | ABBOTT LABORATORIES (US) | 2001-10-25 | — | — | WO | disclosed |
| US-6291504-B1 | POTENT INHIBITORS OF THE CLASS OF ENZYMES KNOWN AS CYCLIN DEPENDENT KINASES | DUPONT PHARMACEUTICALS COMPANY | 2001-09-18 | — | — | US | disclosed |
| US-6265426-B1 | CENTRAL NERVOUS SYSTEM DISORDERS | HOFFMANN-LA ROCHE INC. | 2001-07-24 | — | — | US | disclosed |
| EP-1070708-A1 | Triazole and imidazole derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2001-01-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346588-A1 | IMIDAZOPYRIDINE AND OXAZOLOPYRIDINE DERIVATIVES AND ANALOGS THEREOF, METHODS OF PREPARATION THEREOF, METHODS OF HIF-1/2A PATHWAY INHIBITION, AND INDUCTION OF FERROPTOSIS | HIF1AN, HIF1A, EGLN2 | CA1 2197/4885CA2 615/4885KDM4E 1020/4885 |
| US-20020002152-A1 | Hydrazide and alkoxyamide angiogenesis inhibitors | METAP2, METAP1, ANPEP | CA1 970/4885CA2 258/4885KDM4E 1796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.